Nov 9 (Reuters) – Polaryx Therapeutics, Inc: * POLARYX THERAPEUTICS ACTIVATES FIRST CLINICAL TRIAL SITE FOR SOTERIA PHASE 2 BASKET TRIAL OF PLX-200 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Niket Nishant and Utkarsh Hathi Nov 9 (Reuters) - Wall Street's main indexes climbed…
LISBON, Nov 9 (Reuters) - The European Union must rethink security to take into account…
By Sam Tobin LONDON, Nov 9 (Reuters) - Comedian Russell Brand, once one of Britain's…
Nov 9 (Reuters) - Food Innovators Holdings Ltd : * INVESTIGATIONS INTO POTENTIAL MISAPPROPRIATION OF…
Nov 9 (Reuters) - * FDA- PETITIONED TO REMOVE ETHYLENE DICHLORIDE, METHYLENE CHLORIDE, TRICHLOROETHYLENE AS…
SANTIAGO, Nov 9 (Reuters) - Chilean state-owned miner Codelco's copper production will continue falling unless…